The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Systemic lupus erythematosus: all roads lead to type I interferons
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Self-citationSteinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Self-citationChromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Self-citationAnti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
Self-citationIntegral role of IRF-5 in the gene induction programme activated by Toll-like receptors
Takaoka, A., Yanai, H., Kondo, S., Duncan, G., Negishi, H., Mizutani, T., Kano, S.-I., Honda, K., Ohba, Y., Mak, T. W., et al. (2005) · Nature · doi:10.1038/nature03308 · Cited by 1,039
Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., & Tough, D. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00126-1 · Cited by 974
Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J., & Murali-Krishna, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050821 · Cited by 965
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication
Pisitkun, P., Deane, J. A., Difilippantonio, M. J., Tarasenko, T., Satterthwaite, A. B., & Bolland, S. (2006) · Science · doi:10.1126/science.1124978 · Cited by 894
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R., Shlomchik, M. J., Viglianti, G. A., Rifkin, I. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050630 · Cited by 812
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 759
Spontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis
Bolland, S., & Ravetch, J. V. (2000) · Immunity · doi:10.1016/s1074-7613(00)00027-3 · Cited by 752
Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., & Jahnsen, F. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61689-6 · Cited by 730
Self-citationDefective B cell tolerance checkpoints in systemic lupus erythematosus
Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V., & Nussenzweig, M. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042251 · Cited by 717
Self-citationGraham, R. R., Kozyrev, S. V., Baechler, E. C., Reddy, M. V. P. L., Plenge, R. M., Bauer, J. W., Ortmann, W. A., Koeuth, T., Escribano, M. F. G., Collaborative Groups, T. A. A. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1782 · Cited by 671
Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., & Belardelli, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1777 · Cited by 643
Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells
Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N. J., Trapani, J., & Cebon, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1947 · Cited by 611
Sigurdsson, S., Nordmark, G., Göring, H. H. H., Lindroos, K., Wiman, A.-C., Sturfelt, G., Jönsen, A., Rantapää-Dahlqvist, S., Möller, B., Kere, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/428480 · Cited by 607
From T to B and back again: positive feedback in systemic autoimmune disease
Shlomchik, M. J., Craft, J. E., & Mamula, M. J. (2001) · Nature Reviews Immunology · doi:10.1038/35100573 · Cited by 572
Lövgren, T., Eloranta, M., Båve, U., Alm, G. V., & Rönnblom, L. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20254 · Cited by 552
Boulé, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 518
Cross-regulation of TNF and IFN-α in autoimmune diseases
Palucka, A. K., Blanck, J.-P., Bennett, L., Pascual, V., & Banchereau, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408506102 · Cited by 516
Self-citationToll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 516
Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S., Kelly, K. M., Reeves, W. H., Bauer, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051696 · Cited by 513
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
Santiago-Raber, M.-L., Baccala, R., Haraldsson, K. M., Choubey, D., Stewart, T. A., Kono, D. H., & Theofilopoulos, A. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021996 · Cited by 509
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling
Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A., & Golenbock, D. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412584200 · Cited by 411 · cited 1×
“IRF5 is expressed in pDCs and B cells; it appears to be a crucial mediator of TLR7 signaling, because it is activated by TLR7–TLR8 ligation and because its ectopic expression enables type I IFN production in response to TLR7 ligands [64].”
BackgroundBåve, U., Magnusson, M., Eloranta, M.-L., Perers, A., Alm, G. V., & Rönnblom, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3296 · Cited by 380
Evidence for an Interferon-Inducible Gene, Ifi202, in the Susceptibility to Systemic Lupus
Rozzo, S. J., Allard, J. D., Choubey, D., Vyse, T. J., Izui, S., Peltz, G., & Kotzin, B. L. (2001) · Immunity · doi:10.1016/s1074-7613(01)00196-0 · Cited by 356
Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN
Bekeredjian-Ding, I. B., Wagner, M., Hornung, V., Giese, T., Schnurr, M., Endres, S., & Hartmann, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4043 · Cited by 349
Ehlers, M., Fukuyama, H., McGaha, T. L., Aderem, A., & Ravetch, J. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052438 · Cited by 339
Autoimmunity through Cytokine-Induced Dendritic Cell Activation
Banchereau, J., Pascual, V., & Palucka, A. K. (2004) · Immunity · doi:10.1016/s1074-7613(04)00108-6 · Cited by 293
Self-citationMicroarray Analysis of Interferon-regulated Genes in SLE
Crow, M. K., Kirou, K. A., & Wohlgemuth, J. (2003) · Autoimmunity · doi:10.1080/08916930310001625952 · Cited by 287
Jahnsen, F. L., Lund-Johansen, F., Dunne, J. F., Farkas, L., Haye, R., & Brandtzaeg, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4062 · Cited by 271
Self-citationMathian, A., Weinberg, A., Gallegos, M., Banchereau, J., & Koutouzov, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2499 · Cited by 270
Self-citationBlanco, P., Pitard, V., Viallard, J., Taupin, J., Pellegrin, J., & Moreau, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20745 · Cited by 265
Paquette, R. L., Hsu, N. C., Kiertscher, S. M., Park, A. N., Tran, L., Roth, M. D., & Glaspy, J. A. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.358 · Cited by 262
Genetic Modifiers of Systemic Lupus Erythematosus in FcγRIIB−/− Mice
Bolland, S., Yim, Y.-S., Tus, K., Wakeland, E. K., & Ravetch, J. V. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020165 · Cited by 256
Regulation of B Cell Tolerance by the Lupus Susceptibility Gene Ly108
Kumar, K. R., Li, L., Yan, M., Bhaskarabhatla, M., Mobley, A. B., Nguyen, C., Mooney, J. M., Schatzle, J. D., Wakeland, E. K., & Mohan, C. (2006) · Science · doi:10.1126/science.1125893 · Cited by 232
Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus
Blomberg, S., Eloranta, M. L., Cederblad, B., Nordlind, K., Alm, G. L., & Rönnblom, L. (2001) · Lupus · doi:10.1191/096120301678416042 · Cited by 230
DNA DEGRADATION IN DEVELOPMENT AND PROGRAMMED CELL DEATH
Nagata, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115811 · Cited by 230
Toll‐like receptor 9 signaling protects against murine lupus
Wu, X., & Peng, S. L. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21553 · Cited by 220
Type I IFN Protects Against Murine Lupus
Hron, J. D., & Peng, S. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2134 · Cited by 201
Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice
Braun, D. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00109-9 · Cited by 182
Mohty, M., Vialle-Castellano, A., Nunes, J. A., Isnardon, D., Olive, D., & Gaugler, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3385 · Cited by 182
Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype
Worth, A., Thrasher, A. J., & Bobby Gaspar, H. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.05993.x · Cited by 172
The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-α Inducer
Båve, U., Alm, G. V., & Rönnblom, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3519 · Cited by 167
Mancl, M. E., Hu, G., Sangster‐Guity, N., Olshalsky, S. L., Hoops, K. E. M., Fitzgerald-Bocarsly, P. A., Pitha, P. M., Pinder, K. E., & Barnes, B. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500543200 · Cited by 161
Dendritic Cells Control B Cell Growth and Differentiation
Jégo, G., Pascual, V., Palucka, A. K., & Banchereau, J. (2004) · KARGER eBooks · doi:10.1159/000082101 · Cited by 148
Self-citationToll-Like Receptor-7 Modulates Immune Complex Glomerulonephritis
Pawar, R. D., Patole, P. S., Zecher, D., Segerer, S., Kretzler, M., Schlöndorff, D., & Anders, H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070714 · Cited by 133
Blood dendritic cells and DC-poietins in systemic lupus erythematosus
Gill, M. A., Blanco, P., Arce, E., Pascual, V., Banchereau, J., & Palucka, K. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00756-5 · Cited by 101
Self-citationCirculating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration
Shodell, M., SHAH, K., & Siegal, F. P. (2003) · Lupus · doi:10.1191/0961203303lu362xx · Cited by 101
Bondanza, A., Zimmermann, V. S., DellʼAntonio, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.24 · Cited by 93
Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases
Stewart, T. A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00088-6 · Cited by 86
All is not Toll: new pathways in DNA recognition
Wagner, H., & Bauer, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052191 · Cited by 77
Genetics of susceptibility and severity in systemic lupus erythematosus
Croker, J. A., & Kimberly, R. P. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000169360.15701.27 · Cited by 65
Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression
Georgiev, M., Agle, L. M. A., Chu, J. L., Elkon, K. B., & Ashany, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20759 · Cited by 53
Xin, H., D’Souza, S., Jørgensen, T. N., Vaughan, A. T., Lengyel, P., Kotzin, B. L., & Choubey, D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5863 · Cited by 47
Lauwerys, B. R., & Wakeland, E. K. (2005) · Lupus · doi:10.1191/0961203305lu2052oa · Cited by 42 · cited 2×
“Even though they display high autoantibody titers, these mice do not develop further SLE manifestations unless crossed with mice carrying other lupus-prone genetic intervals (reviewed in [68]).”
Background
Cited by
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., Huang, X., Zhou, H., de Vries, N., Tak, P. P., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24436 · Cited by 735
Brodin, P., & Davis, M. M. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2016.125 · Cited by 730
Deane, J. A., Pisitkun, P., Barrett, R. S., Feigenbaum, L., Town, T., Ward, J. M., Flavell, R. A., & Bolland, S. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.009 · Cited by 636
Metadata
- Authors
- Pascual, V., Farkas, L., & Banchereau, J.
- Venue
- Current Opinion in Immunology
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 18
- Issue
- 6
- Pages
- 676-682
- ISSN
- 0952-7915 (ISSN-L)
- OpenAlex
- W2144081036
- Cited by
- 285
- References
- 69
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.